Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in France, in the United Kingdom, in Belgium, .... It is testing Long-Term Impact on Functioning using Atomoxetine Hydrochloride Compared to Other Early Standard Care for ADHD.
In Belgium
This study is completed in Belgium, in Germany, in Poland, .... It is testing intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.
In BelgiumThis study is completed in Belgium, in Slovakia, in Hungary, .... It is testing efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant for Depression.
In BelgiumThis study is completed in the United Kingdom, in Belgium, in Sweden, .... It is testing efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant for Depression.
In Belgium
This study is completed in Belgium and in Estonia. It is testing Flexibly-Dosed Extended-Release Paliperidone for Bipolarity.
In BelgiumThis study is completed in Belgium, in Czechia, in Spain, .... It is testing Paliperidone Palmitate 3 Month and 1 Month Formulations for schizophrenia.
In BelgiumThis study is completed in France, in Belgium, in the Netherlands, .... It focuses on Depression.
In BelgiumThis summary needs review. Please check the official study record and contact the research team for details.
In BelgiumThis study is completed in Belgium, in Germany, and in the Netherlands. It is testing JNJ-42847922 for depression.
In BelgiumThis study is completed in France, in the United Kingdom, in Belgium, .... It focuses on ADHD.
In BelgiumThis study is completed in France, in Belgium, in the Netherlands, .... It is testing aripiprazole for schizophrenia.
In BelgiumThis study was terminated in the United States, in Belgium, in Brazil, .... It is testing Aticaprant 10 mg for depression.
In BelgiumHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.